Cargando…
Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4
BACKGROUND: Fifty percent of lung adenocarcinomas harbor somatic mutations in six genes that encode proteins in the EGFR signaling pathway, i.e., EGFR, HER2/ERBB2, HER4/ERBB4, PIK3CA, BRAF, and KRAS. We performed mutational profiling of a large cohort of lung adenocarcinomas to uncover other potenti...
Autores principales: | Marks, Jenifer L., McLellan, Michael D., Zakowski, Maureen F., Lash, Alex E., Kasai, Yumi, Broderick, Stephen, Sarkaria, Inderpal S., Pham, DuyKhanh, Singh, Bhuvanesh, Miner, Tracie L., Fewell, Ginger A., Fulton, Lucinda L., Mardis, Elaine R., Wilson, Richard K., Kris, Mark G., Rusch, Valerie W., Varmus, Harold, Pao, William |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855985/ https://www.ncbi.nlm.nih.gov/pubmed/17487277 http://dx.doi.org/10.1371/journal.pone.0000426 |
Ejemplares similares
-
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
por: Pao, William, et al.
Publicado: (2005) -
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
por: Pao, William, et al.
Publicado: (2005) -
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
por: Welander, Jenny, et al.
Publicado: (2017) -
Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes
por: Walter, Matthew J., et al.
Publicado: (2011) -
Activating Somatic FGFR2 Mutations in Breast Cancer
por: Reintjes, Nadine, et al.
Publicado: (2013)